Pyridine Derivatives As Vegfr-2 Receptor And Protein Tyrosine Kinase Inhibitors


The invention relates to compounds of general formula (I) wherein W, D, E, G, J, L, R1, R2, R3, R4, R5 and Y are as defined herein, and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use -alone or in combination with one or more other pharmaceutically active compounds- in therapy, for treating diseases associated with deregulated angiogenesis, such as cancer and skin and eye diseases.

Download PDF
Document Preview
Document History
  • Publication: Mar 4, 2010
  • Application: Aug 27, 2009
    WO DK 2009000190 W
  • Priority: Oct 17, 2008
    DK DK PA200801449 A
  • Priority: Aug 27, 2008
    US US 9221308 P

Sign in to the Lens